Dr. Pankaj Mathur, MD

Dr. Mathur practices at SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care.

Dr. Mathur's NPI, 1578986212, was assigned on January 31, 2014. Dr. Mathur holds Missouri license 2025006675.

Dr. Mathur's primary practice is SSM Health Saint Louis University Hospital, at 1201 S Grand Blvd, Saint Louis, MO 63104 in St. Louis City. The practice phone is (314) 257-8000.

Dr. Mathur's primary practice is SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care. Dr. Mathur is also affiliated with SSM Health St. Mary's Hospital - St. Louis. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Mathur to 2 more hospitals, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mathur practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mathur's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Mathur's licenses on file in 2 states: Missouri and Arkansas.

CMS data shows 274 Medicare services from Dr. Mathur across 7 procedure codes in 2024, for 229 Medicare patients. Medicare paid $12,896 for them.

CMS counts 229 Medicare patients who saw Dr. Mathur in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mathur's median patient age at 69, with 45% women.

In 2024, Dr. Mathur wrote 370 Medicare Part D claims for 77 patients. 91% of them were for generic drugs. CMS names the drug for 265 of them, across 11 drugs with 11 or more claims each, at $1,905 in total drug cost. In 2023, CMS named 95 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 60 out of 100 for Dr. Mathur for performance year 2024, reported through an alternative payment model (APM). Dr. Mathur accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 30 papers to Dr. Mathur, published from 2015 to 2024. 2021 was the busiest year, with 7. The most frequent topics are Multiple Myeloma, Antihypertensive Agents and Atherosclerosis. Dr. Mathur has published most often in Am Heart J Plus. Dr. Mathur's most frequent co-authors are Sharmilan Thanendrarajan, MD, Jawahar L. Mehta, MD and Carolina D. Schinke, MD.

Dmand AI links Dr. Mathur to 6 clinical trials, 5 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Neoplasms, Plasma Cell. University of Arkansas sponsors the most, 6.

CMS Open Payments shows 9 general payments to Dr. Mathur from 7 drug and device companies from 2016 to 2025. Education make up the largest share, 55% of the total. Abbott Laboratories paid the most, $517.